International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.
about
Advanced therapies for end-stage heart failureCardiac allograft vasculopathy: diagnosis, therapy, and prognosis.Leakage and water exchange characterization of gadofosveset in the myocardium.ST Elevation Infarction after Heart Transplantation Induced by Coronary Spasms and Mural Thrombus Detected by Optical Coherence Tomography.Donor-Transmitted Atherosclerosis Associated With Worsening Cardiac Allograft Vasculopathy After Heart Transplantation: Serial Volumetric Intravascular Ultrasound AnalysisCoronary microvasculopathy in heart transplantation: Consequences and therapeutic implications.The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection.The detection of coronary stiffness in cardiac allografts using MR imaging.Cellular and Functional Imaging of Cardiac Transplant Rejection.Ischemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantationEpitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.The link between major histocompatibility complex antibodies and cell proliferation.Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.Immunomodulatory Strategies Directed Toward Tolerance of Vascularized Composite Allografts.Reduced progression of cardiac allograft vasculopathy with routine use of induction therapy with basiliximabKidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma.HLA class I: an unexpected role in integrin β4 signaling in endothelial cellsDobutamine stress echocardiography after cardiac transplantation: implications of donor-recipient age difference.The clinical course and outcomes of post-transplantation diabetes mellitus after heart transplantationDonor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study.VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipientsMyocardial infarction in an adult with cystic fibrosis and heart and lung transplant.Serial changes in longitudinal graft function and implications of acute cellular graft rejections during the first year after heart transplantation.A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantationMulticenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 StudyCoronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomographyLate outcome after paediatric heart transplantation in Finland.Erythroblast transformation-specific 2 correlates with vascular smooth muscle cell apoptosis in rat heterotopic heart transplantation modelCoronary collaterals predict improved survival and allograft function in patients with coronary allograft vasculopathy.Cardiac allograft vasculopathy in Dutch heart transplant recipients.HLA class I antibody-mediated endothelial and smooth muscle cell activation.Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells.Toxoplasma gondii serostatus is not associated with impaired long-term survival after heart transplantation.Induction of cardiac allograft tolerance across a full MHC barrier in miniature swine by donor kidney cotransplantation.T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model.Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft InjuryEverolimus: efficacy and safety in cardiac transplantation.
P2860
Q26992073-1D21B6BC-0213-40D6-85AB-841777A88AA2Q27011330-FADD0350-AEF3-4316-8590-69CCE77ED76BQ30732433-EB8D94CC-248D-4FC9-9842-715372B01329Q30830320-3203B58D-6090-4464-8655-9D58C3BD45D9Q33719657-205B7FDF-4624-4760-9A31-293AE7070470Q33891755-AAB7A5A9-D8FA-4C7B-9358-31904249B38CQ33911449-6A7CD772-A7DA-4C6F-AF68-96F37A45BE7DQ34118053-7BB49C98-BCDA-46E4-874B-839466428C41Q34606815-7FC131E4-519A-4BA1-B84C-8F9B0CA158F8Q35026402-334264F2-C0C2-4793-906D-B1396EE255D8Q35050517-07482DC8-A4F1-4BAD-AD2A-AAF00552B92DQ35091339-5C234467-C9E9-4983-AB3E-587A7F6CADD3Q35139244-1E97F8A9-EC9A-4947-8B19-B4C8EECC33A2Q35223952-030471C4-90BD-4355-8904-DA6FC13D793EQ35469913-C1421085-B8B4-49A4-9B39-4E8B1F10DC6CQ36001563-6CC9A884-6C15-4BFB-A7DD-C96DCB809908Q36024257-16E77503-649F-4ED0-9B06-E880598BDDF4Q36047265-74C0EB3E-8055-450A-8333-86F315386623Q36360674-761545C8-A6D8-40A7-9251-15D9D5D07964Q36365080-8436FF40-C442-47B2-ACF7-690C958EFF5EQ36472935-8E3F6B2D-BB38-4371-8402-C5B1A267C74FQ36554486-1CB53401-5923-40CD-9932-BA7F92D111CAQ36684948-1C54DF19-0744-4AEB-AB07-9125BE9EB63EQ36921738-67961CEE-51F6-4AA5-9D06-409AA81599ACQ36942171-F32704E0-0873-4832-8362-5B4E7B2AEBC9Q37044200-F5ED5FE8-F104-4D8C-A21F-70CA99103576Q37056572-760DBAC7-36FD-4764-9691-C5346709F7BDQ37101630-7707F451-A8B9-4AAF-A36B-28E9259B2DBAQ37136440-119A7E7E-A914-482C-98A6-A397EA9DAD2BQ37179616-567428ED-31B8-4B53-8679-D0EAD274B1EDQ37208630-AD223274-72BF-4125-A590-6413B19C4CD8Q37391940-19DAC7AB-AFA1-4CBF-84E1-6778CFB9FF52Q37430110-D7AB70CC-407B-4D7C-831A-0781FA649056Q37430871-66198F06-5F51-4191-AEF0-40E0F21CB86BQ37453921-1EAC6596-0000-4841-A426-1683FCC81F35Q37464884-47C38D4F-DF1C-463B-995D-9C93CBE17337Q37577538-01A144F6-DB8F-4C99-A57E-C1D396F92CA0Q37709825-DC8A33B0-DEBD-4AF7-B3A0-53272EDDE295Q37720377-A0F7439B-1841-43E8-97A4-17566354B9E3Q37779322-D1A2E8AA-0AEB-4B87-AD68-0A8B3091380B
P2860
International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
International Society for Hear ...... c allograft vasculopathy-2010.
@en
International Society for Hear ...... c allograft vasculopathy-2010.
@nl
type
label
International Society for Hear ...... c allograft vasculopathy-2010.
@en
International Society for Hear ...... c allograft vasculopathy-2010.
@nl
prefLabel
International Society for Hear ...... c allograft vasculopathy-2010.
@en
International Society for Hear ...... c allograft vasculopathy-2010.
@nl
P2093
P50
P1476
International Society for Hear ...... ac allograft vasculopathy-2010
@en
P2093
Anne Dipchand
Jayan Parameshwar
Joren Madsen
Maria G Crespo-Leiro
Nicola E Hiemann
Patricia A Uber
Stephan M Ensminger
P304
P356
10.1016/J.HEALUN.2010.05.017
P577
2010-07-01T00:00:00Z